Foresite Capital Management I, LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Foresite Capital Management I, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Foresite Capital Management I, LLC. Foresite Capital Management I, LLC is 10% Owner in AMBIT BIOSCIENCES CORP ($AMBI) and 10% Owner in 10x Genomics, Inc. ($TXG).
Latest Insider Trading Transactions of Foresite Capital Management I, LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 14 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,930,198 | 0 | 0 | |
May 14 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | S | 80.13 | 650,000 | 52,084,500 | 2,350,000 | 3 M to 2.4 M (-21.67 %) |
May 14 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | S | 80.13 | 800,000 | 64,104,000 | 3,500,000 | 4.3 M to 3.5 M (-18.60 %) |
May 14 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 1,930,198 | 0 | 4,300,000 | 2.4 M to 4.3 M (+81.45 %) |
May 08 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,500,000 | 0 | 3,153,528 | |
May 08 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 500,000 | 0 | 1,930,198 | |
May 08 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 1,500,000 | 0 | 3,000,000 | 1.5 M to 3 M (+100.00 %) |
May 08 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 500,000 | 0 | 2,369,802 | 1.9 M to 2.4 M (+26.74 %) |
Apr 24 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,000,000 | 0 | 2,430,198 | |
Apr 24 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 1,000,000 | 0 | 1,869,802 | 869.8 K to 1.9 M (+114.97 %) |
Apr 24 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 92,258 | 0 | 327,383 | 235.1 K to 327.4 K (+39.24 %) |
Apr 24 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 178,584 | 0 | 0 | 178.6 K to 0 (-100.00 %) |
Apr 24 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 178,584 | 0 | 178,584 | 0 to 178.6 K |
Apr 24 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 700,000 | 0 | 869,802 | 1.6 M to 869.8 K (-44.59 %) |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,500,000 | 0 | 4,653,528 | |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 1,500,000 | 0 | 1,500,000 | 0 to 1.5 M |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 109,849 | 0 | 235,125 | 125.3 K to 235.1 K (+87.69 %) |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 21,686 | 0 | 0 | 21.7 K to 0 (-100.00 %) |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 21,686 | 0 | 21,686 | 0 to 21.7 K |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 201,115 | 0 | 0 | 201.1 K to 0 (-100.00 %) |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 201,115 | 0 | 201,115 | 0 to 201.1 K |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 433,725 | 0 | 0 | 433.7 K to 0 (-100.00 %) |
Apr 15 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 788,317 | 0 | 1,569,802 | 2.4 M to 1.6 M (-33.43 %) |
Mar 26 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 2,170,619 | 0 | 3,430,198 | |
Mar 26 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 2,170,619 | 0 | 2,358,119 | 187.5 K to 2.4 M (+1,157.66 %) |
Mar 26 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 2,170,619 | 0 | 3,430,198 | |
Mar 26 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 2,170,619 | 0 | 2,358,119 | 187.5 K to 2.4 M (+1,157.66 %) |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 683,725 | 0 | 6,153,528 | |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,447,079 | 0 | 5,600,817 | |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 125,276 | 0 | 125,276 | 0 to 125.3 K |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 241,619 | 0 | 0 | 241.6 K to 0 (-100.00 %) |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | J | 0.00 | 241,619 | 0 | 241,619 | 0 to 241.6 K |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | J | 0.00 | 947,079 | 0 | 187,500 | 1.1 M to 187.5 K (-83.47 %) |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | S | 59.00 | 250,000 | 14,750,000 | 433,725 | 683.7 K to 433.7 K (-36.56 %) |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Sell | S | 59.00 | 500,000 | 29,500,000 | 1,134,579 | 1.6 M to 1.1 M (-30.59 %) |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 683,725 | 0 | 683,725 | 0 to 683.7 K |
Mar 19 2020 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | C | 0.00 | 1,447,079 | 0 | 1,634,579 | 187.5 K to 1.6 M (+771.78 %) |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 6,837,253 | 0 | 6,837,253 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 7,047,896 | 0 | 7,047,896 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,324,195 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 5,513,058 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 558,260 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 1,002,166 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Option Exercise | C | 0.00 | 5,487,470 | 0 | 0 | |
Sep 16 2019 | TXG | 10x Genomics, Inc. | Foresite Capital Management I, ... | 10% Owner | Buy | P | 39.00 | 187,500 | 7,312,500 | 187,500 | 0 to 187.5 K |
Oct 16 2013 | AMBI | AMBIT BIOSCIENCES ... | Foresite Capital Management I, ... | 10% Owner | Buy | P | 6.77 | 4,817 | 32,594 | 2,079,569 | 2.1 M to 2.1 M (+0.23 %) |
Oct 16 2013 | AMBI | AMBIT BIOSCIENCES ... | Foresite Capital Management I, ... | 10% Owner | Buy | P | 7.46 | 7,500 | 55,962 | 2,074,752 | 2.1 M to 2.1 M (+0.36 %) |
Oct 16 2013 | AMBI | AMBIT BIOSCIENCES ... | Foresite Capital Management I, ... | 10% Owner | Buy | P | 7.45 | 5,700 | 42,483 | 2,067,252 | 2.1 M to 2.1 M (+0.28 %) |
Oct 16 2013 | AMBI | AMBIT BIOSCIENCES ... | Foresite Capital Management I, ... | 10% Owner | Buy | P | 6.99 | 10,000 | 69,908 | 2,061,552 | 2.1 M to 2.1 M (+0.49 %) |
Oct 16 2013 | AMBI | AMBIT BIOSCIENCES ... | Foresite Capital Management I, ... | 10% Owner | Buy | P | 6.74 | 5,005 | 33,729 | 2,051,552 | 2 M to 2.1 M (+0.24 %) |
Oct 16 2013 | AMBI | AMBIT BIOSCIENCES ... | Foresite Capital Management I, ... | 10% Owner | Buy | P | 6.84 | 1,811 | 12,380 | 2,046,547 | 2 M to 2 M (+0.09 %) |
Oct 16 2013 | AMBI | AMBIT BIOSCIENCES ... | Foresite Capital Management I, ... | 10% Owner | Buy | P | 6.90 | 8,120 | 56,048 | 2,044,736 | 2 M to 2 M (+0.40 %) |
Oct 16 2013 | AMBI | AMBIT BIOSCIENCES ... | Foresite Capital Management I, ... | 10% Owner | Buy | P | 6.77 | 36,616 | 247,953 | 2,036,616 | 2 M to 2 M (+1.83 %) |
Page: 1